# SAD and MAD Study of AKB-9090 in Healthy Adult Participants

> **NCT07429006** · PHASE1 · RECRUITING · sponsor: **Akebia Therapeutics** · enrollment: 70 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AKB-9090
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07429006
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-16
- **Primary completion:** 2026-10
- **Final completion:** 2026-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429006, "SAD and MAD Study of AKB-9090 in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07429006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*